FDA wants new warning on OTC chlorhexidine

6 February 2017 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) has asked manufacturers of OTC antiseptic products containing chlorhexidine gluconate to add a warning to the Drug Facts labels about the risk of "rare but serious allergic reactions".

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: